Paper

IGLV3‐21 R110 and ibrutinib treatment: Results from the double‐blind, randomized, placebo‐controlled GCLLSG CLL12 trial in early‐stage CLL

HemaSphere · 2026 · Deyan Y Yosifov, Sandra Robrecht, Adam Giza et al.